PD-L1 is expressed on the surface of cancer cells, where it can interact with the receptor, PD-1 on the T cell membrane to suppress the immune response against tumors (Dong et al., 2018; Ribas and Wolchok 2018). The gene discussed is CD274; the disease is cancer.